Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
MaxCyte, Inc. (MXCT) is a company in the Health care sector; its shares trade on Nasdaq.
The price of MaxCyte, Inc. (MXCT) on October 30, 2026 is 1.57 $, −8.96 % on the day. Over 52 weeks the stock traded between 0.6430 $ and 1.86 $; the price now sits 76 % of the way up that range. Over the past year the price changed by −24.24 %. Market capitalization is 167.16 million $, rank 7 among 10 stocks of the same industry with a known capitalization.
MaxCyte, Inc. trades on Nasdaq under the ticker MXCT. The company belongs to the Health care sector. The trading history on this page starts on 30 July 2021.
Over the past 52 weeks MXCT has traded between 0.6430 $ and 1.87 $. As of 30 October 2026 the price stood 49.67 % of the way from the 52-week low to the high.
Over one year MXCT shares fell 24.24 %; over six months they rose 47.93 %. Volatility over 90 days is 70.58 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 5.4, above the sector median of 3.6. Price to book is 1.1, below the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
MaxCyte, Inc. reported revenue of 31M $ and a net loss of 36M $ over the last four quarters. Net margin is −114.77 %. Revenue changed by −13.15 % year over year. Earnings per share are −0.34 $. Market capitalisation is 167M $.
MXCT has a return on equity of −22.45 %, above the sector median of −40.58 %. Return on assets is −19.30 %, above the sector median of −30.08 %. Operating margin is −134.59 %, below the sector median of −20.96 %.